Cargando…

Tumefactive Fibroinflammatory Lesion: A Diagnostic Dilemma

Tumefactive fibroinflammatory lesions (TFLs) are rare idiopathic benign fibrosclerosing lesions that clinically simulate a malignancy. TFLs are seen more frequently in males between 10 and 74 years of age. The usual site of involvement is the head and neck region, but rarely the extremities may be i...

Descripción completa

Detalles Bibliográficos
Autores principales: Jain, Promil, Sen, Rajeev, Sharma, Nisha, Bhargava, Shilpi, Singh, Virender
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Iranian Journal of Medical Sciences 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5366370/
https://www.ncbi.nlm.nih.gov/pubmed/28360448
_version_ 1782517579259052032
author Jain, Promil
Sen, Rajeev
Sharma, Nisha
Bhargava, Shilpi
Singh, Virender
author_facet Jain, Promil
Sen, Rajeev
Sharma, Nisha
Bhargava, Shilpi
Singh, Virender
author_sort Jain, Promil
collection PubMed
description Tumefactive fibroinflammatory lesions (TFLs) are rare idiopathic benign fibrosclerosing lesions that clinically simulate a malignancy. TFLs are seen more frequently in males between 10 and 74 years of age. The usual site of involvement is the head and neck region, but rarely the extremities may be involved. Coexisting fibrosclerotic processes have been reported including retroperitoneal fibrosis, sclerosing cholangitis, sclerosing mediastinal fibrosis, and orbital pseudotumors. The etiology of this poorly understood entity remains unknown. Possible suggestions include exaggerated responses or autoimmune reactions to any chronic infection. The clinical and radiological appearance of TFLs is that of malignancy, but histopathology reveals them to be a benign process broadly classified under non-neoplastic, fibroinflammatory proliferations. The treatment strategies for these lesions are not well defined and variable and include steroids, surgery, and radiotherapy either alone or in combination. TFLs, albeit not fatal, have a high recurrence rate; patients should, therefore, be kept on long-term follow-up. We describe a young female patient presenting with a rapidly developing cheek swelling, which was diagnosed histopathologically as a TFLs.
format Online
Article
Text
id pubmed-5366370
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Iranian Journal of Medical Sciences
record_format MEDLINE/PubMed
spelling pubmed-53663702017-03-30 Tumefactive Fibroinflammatory Lesion: A Diagnostic Dilemma Jain, Promil Sen, Rajeev Sharma, Nisha Bhargava, Shilpi Singh, Virender Iran J Med Sci Case Report Tumefactive fibroinflammatory lesions (TFLs) are rare idiopathic benign fibrosclerosing lesions that clinically simulate a malignancy. TFLs are seen more frequently in males between 10 and 74 years of age. The usual site of involvement is the head and neck region, but rarely the extremities may be involved. Coexisting fibrosclerotic processes have been reported including retroperitoneal fibrosis, sclerosing cholangitis, sclerosing mediastinal fibrosis, and orbital pseudotumors. The etiology of this poorly understood entity remains unknown. Possible suggestions include exaggerated responses or autoimmune reactions to any chronic infection. The clinical and radiological appearance of TFLs is that of malignancy, but histopathology reveals them to be a benign process broadly classified under non-neoplastic, fibroinflammatory proliferations. The treatment strategies for these lesions are not well defined and variable and include steroids, surgery, and radiotherapy either alone or in combination. TFLs, albeit not fatal, have a high recurrence rate; patients should, therefore, be kept on long-term follow-up. We describe a young female patient presenting with a rapidly developing cheek swelling, which was diagnosed histopathologically as a TFLs. Iranian Journal of Medical Sciences 2017-03 /pmc/articles/PMC5366370/ /pubmed/28360448 Text en Copyright: © Iranian Journal of Medical Sciences http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Jain, Promil
Sen, Rajeev
Sharma, Nisha
Bhargava, Shilpi
Singh, Virender
Tumefactive Fibroinflammatory Lesion: A Diagnostic Dilemma
title Tumefactive Fibroinflammatory Lesion: A Diagnostic Dilemma
title_full Tumefactive Fibroinflammatory Lesion: A Diagnostic Dilemma
title_fullStr Tumefactive Fibroinflammatory Lesion: A Diagnostic Dilemma
title_full_unstemmed Tumefactive Fibroinflammatory Lesion: A Diagnostic Dilemma
title_short Tumefactive Fibroinflammatory Lesion: A Diagnostic Dilemma
title_sort tumefactive fibroinflammatory lesion: a diagnostic dilemma
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5366370/
https://www.ncbi.nlm.nih.gov/pubmed/28360448
work_keys_str_mv AT jainpromil tumefactivefibroinflammatorylesionadiagnosticdilemma
AT senrajeev tumefactivefibroinflammatorylesionadiagnosticdilemma
AT sharmanisha tumefactivefibroinflammatorylesionadiagnosticdilemma
AT bhargavashilpi tumefactivefibroinflammatorylesionadiagnosticdilemma
AT singhvirender tumefactivefibroinflammatorylesionadiagnosticdilemma